Jeremy Yethon

Jeremy Yethon has over 20 years of work experience in the field of biology and microbiology. Jeremy is currently working as the VP of Biology at Apriori Bio since December 2022. Prior to that, Jeremy held the position of VP of Biology at Kaleido Biosciences from 2020 to 2022, where they led multidisciplinary teams and established a long-term investment plan for platform technology. Before that, they served as the Senior Director of Microbiome Sciences at Kintai Therapeutics from 2019 to 2020 and as the Senior Director of Microbiology at Seres Therapeutics from 2018 to 2019. Jeremy also has a strong background in academia, having worked as the Head of Bacteriology and various other roles at Sanofi Pasteur from 2005 to 2018. Their earlier experience includes a role as a Scientist at Affinium Pharmaceuticals and a Postdoctoral Fellow at McMaster University.

Jeremy Yethon holds a PhD in Microbiology from the University of Guelph. No specific information regarding the start or end year of their education at this institution is provided.